-

Business Separation Transactions: Spin-Offs, Subsidiary IPOs and Tracking Stock - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Business Separation Transactions. Spin-Offs, Subsidiary IPOs and Tracking Stock" book has been added to ResearchAndMarkets.com's offering.

Why have some of the nation's most prominent corporations engaged in spin-offs and split-offs? What should you know about structuring these transactions for companies of any size? How do they compare to traditional M&A transactions?

Finally, there is a book that examines the hows and whys of this vital corporate strategy. "Business Separation Transactions: Spin-Offs, Subsidiary IPOs and Tracking Stock" explains the objectives underlying these transactions, the techniques used, and the consequences for all parties.

You'll find extensive discussion of management's goals, the significance of stock market conditions, and the legal, tax and accounting issues involved in every scenario - plus sample agreements, registration statements and other helpful documents.

Whatever your reason for contemplating a business separation transaction - improving management focus, eliminating competition between business units, reducing costs of raising capital - this problem-solving guide helps you achieve your objectives while satisfying legal requirements.

You'll also find coverage of employee benefits, creditors' rights, and other legal issues that may arise at any stage of a transaction. This book is a vital resource for anyone who advises management or has responsibility for making key decisions.

For more information about this book visit https://www.researchandmarkets.com/r/p786v4

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

2 Day Pharma Professionals Project Management Training Course (Online Event: Mar 9th - Mar 10th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Project Management for Pharma Professionals Training Course (Mar 9th - Mar 10th, 2026)" training has been added to ResearchAndMarkets.com's offering. This interactive two-day course has been designed to provide you with a thorough understanding of both technical and interpersonal project management skills. Drug and device development is a complex process which needs effective project management. With ever-increasing pressures in the industry, the use of project man...

Lithuania Defense Industry Research 2025: Market Size and Trends, Budget Allocation, Regulations, Key Acquisitions, Competitive Landscape and Forecasts 2024-2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Lithuania Defense Market - Size and Trends, Budget Allocation, Regulations, Key Acquisitions, Competitive Landscape and Forecast, 2025-2030" report has been added to ResearchAndMarkets.com's offering. Lithuania Defense Market report provides the market size forecast and the projected growth rate for the next five years. The report covers industry analysis including the key market drivers, emerging technology trends, and major challenges faced by market participants...

A Practical Guide to Writing Risk Management Plans (RMPs) Training Course: Advice on EU Risk Management Plans for New Products (Mar 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--"A Practical Guide to Writing Risk Management Plans (RMPs) Training Course (Mar 20, 2026)" has been added to ResearchAndMarkets.com's offering. In the EU, all companies are required to provide risk management plans (RMPs) for every new product, whether generic products or new chemical entities, and these RMPs must also be modified and updated throughout the lifetime of a medicine. This intensive one-day course will provide you with an invaluable overview of writing and...
Back to Newsroom